When I tell people that I work with children fleeing persecution, I can see the darkness of what that means come across their face as they comment on how hard that must be. And of course, it is.

Sean Sheehan has been to World of Concrete so many times, he can’t remember if this is his eighth or ninth time attending the construction industry’s huge annual trade show.

Now, more than a year later since the coronavirus pandemic began, the prospect of re-entering the classroom en masse is fast-approaching reality for tens of thousands of Nevada students, including thousands who have never set foot on their own school campus.

If you’re vaccinated and wondering whether you should butt in and try to persuade others to get vaccinated, too, you’re not alone.

Now that the FDA has approved Biogen's aducanumab (Aduhelm), the controversial new drug for Alzheimer's disease, what does this mean?

From just 1,200 cases spread out over 18 months, Taiwan now tops 10,000. Though low compared to other parts of East Asia, it has been a major confidence blow as Taiwan has been hailed globally for its successful strategy in keeping COVID-19 at bay.

In a watershed moment for the field, the U.S. Food and Drug Administration yesterday approved the first Alzheimer’s treatment that tackles the underlying disease pathology.

The first drug to treat Alzheimer’s disease in 18 years, which was extensively researched at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, has won approval from the Food and Drug Administration.

Progressives are livid at Sen. Joe Manchin, D-W.V. — once again.